Rapid real-time fluorescent PCR gene dosage test for the diagnosis of DNA duplications and deletions

Clinical Chemistry

Volumn 46, Issue 10, 2000, Pages 1574-1582

  Ruiz Ponte, C ^a   Loidi, L ^a   Vega, A ^a   Carracedo, A ^a   Barros, F ^a  

^a HOSPITAL DE CONXO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICROSATELLITE DNA;

ACCURACY; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MELTING POINT; NEUROPATHY; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0033775696     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.10.1574     Document Type: Article

References (34)

1. DNA duplication associated with Charcot-Marie-Tooth disease type 1A
2. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1A (CMT1A)
3. DNA deletion associated with hereditary neuropathy with liability to pressure palsies
4. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A
5. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A
6. Localization of PMP-22 gene (candidate gene for the Charcot-Marie-Tooth disease type 1A) to band 17p11.2 by direct R-banding fluorescence in situ hybridization
7. The peripheral myelin protein gene PMP22 is contained within the Charcot-Marie-Tooth disease type 1A duplication
8. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A
9. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A
10. Inherited primary peripheral neuropathies: Molecular genetics and clinical implications of CMT1A and HNPP
11. Hypermyelination and demyelinating peripheral neuropathies in PMP22 deficient mice
12. DNA diagnosis for Charcot-Marie-Tooth disease and related inherited neuropathies
13. Diagnosis of the CMT1A duplication and HNPP deletion by interphase FISH: Implications for testing in the cytogenetic laboratory
14. Assignment of microsatellite sequences to the region duplicated in CMT1A (17p12): A useful tool for diagnosis
15. Microsatellite mapping of the deletion in patients with hereditary neuropathy with liability to pressure palsies (HNPP): New molecular tools for the study of the region 17p12-p11 and for diagnosis
16. Polymorphisms in the PMP22 gene region (17p11.2-p12) are crucial for simplified diagnosis of duplications/deletions
17. PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A
18. Determination of gene dosage at the PMP22 and androgen receptor loci by quantitative PCR
19. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction
20. In vivo and in vitro regulation of erythropoietin mRNA: Measurement by competitive polymerase chain reaction
21. Rapid quantification of gene expression by competitive RT-PCR and ion-pair reversed-phase HPLC
22. Direct quantitation of RNA transcripts by competitive single-tube RT-PCR and capillary electrophoresis
23. Continuous fluorescence monitoring of rapid cycle DNA amplification
24. The LightCycler(TM): A microvolume multisample fluorimeter with rapid temperature control
25. LightCycler technology for the quantitation of bcr/abl fusion transcripts
26. A frameshift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies
27. Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template
28. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates
29. Fluorescence monitoring of rapid cycle PCR for quantification
30. A commentary on the practical applications of competitive PCR
31. Technical aspects of quantitative competitive PCR
32. Quantitative RT-PCR: Pitfalls and potential
33. Gene dosage by quantitative real-time PCR